Search results
Results from the WOW.Com Content Network
(R)-[11 C]PK 11195 has been used in positron emission tomography (PET) scanning to visualize brain inflammation in patients with neuronal damage. Increases in ( R )-[ 11 C]PK 11195 binding have been reported in patients with stroke, traumatic brain injury [ 5 ] and in patients with chronic neurodegenerative conditions including Huntington's ...
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
Drug delivery to the brain is the process of passing therapeutically active molecules across the blood–brain barrier into the brain.This is a complex process that must take into account the complex anatomy of the brain as well as the restrictions imposed by the special junctions of the blood–brain barrier.
An FDA advisory panel recently recommended the approval of Sanofi's multiple sclerosis drug, Lemtrada. However, that approval came among some mixed and contradictory opinions about the drug and ...
Sanofi quoted Houman Ashrafian, its head of research and development, as saying that it "represents an unprecedented breakthrough as a potential first-in-disease treatment option with clinically ...
Sanofi , one of the largest pharmaceutical companies on the planet, was in a dire situation when CEO Chris Viehbacher took the reins in late 2008.Over the last five years, however, the company has ...
Japanese encephalitis vaccines first became available in the 1930s. [3] One of them was an inactivated mouse brain-derived vaccine (the Nakayama and/or Beijing-1 strain), made by BIKEN and marketed by Sanofi Pasteur as JE-VAX, until production ceased in 2005.
The first results of Sanofi’s OpenAI collaboration should be in by the end of 2024 and will most likely take the form of AI-generated first drafts of FDA documents. The results of the more ...